Mark A Glickman
CIK 1441461 · Co-Chief Executive Officer · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$85.5K
Companies
7
Total Filings
28
Lifetime Open-Market Net
-$1.51M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MetaVia Inc. (NRBO) Delisted | Director | 20,629 | $2.36 | $48.7K | $0 | 4 | 2026-06-08 |
| TXMD | Co-Chief Executive Officer | 1,734 | $2.20 | $3.8K | -$2.2K | 4 | 2022-12-09 |
| ESPR | Chief Commercial Officer | 25,925 | $3.15 | $81.7K | $0 | 1 | 2020-01-03 |
| Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Chief Commercial Officer | 250,188 | — | — | $82.3K | 7 | 2018-03-21 |
| POZEN INC /NC (POZN) Delisted | Chief Commercial Officer | 29,137 | — | — | $0 | 1 | 2015-06-24 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | EVP - Sales and Marketing | 0 | — | — | -$1.59M | 10 | 2015-01-30 |
| OSCIENT PHARMACEUTICALS CORP (OSCI) Delisted | SVP, Sales & Marketing | 36,157 | — | — | $0 | 1 | 2008-07-30 |
Recent Filings · Page 2 of 3
28 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-05-12 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Grant (A) | +80,163 | $0 | EDGAR |
| 2016-06-24 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Tax (F) | −10,803 | -$36.1K | EDGAR |
| 2016-05-18 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Buy (P) | +25,000 | $92.0K | EDGAR |
| 2016-03-18 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Grant (A) | +45,553 | $0 | EDGAR |
| 2016-02-17 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Grant (A) | +86,863 | $0 | EDGAR |
| 2016-02-09 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Other (J) | +29,137 | $0 | EDGAR |
| 2015-06-24 | POZEN INC /NC (POZN) Delisted | Grant (A) | +29,137 | $0 | EDGAR |
| 2015-01-30 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Other (J) | −27,911 | -$1.02M | EDGAR |
| 2014-11-24 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Mixed | −7,202 | -$753.1K | EDGAR |
| 2014-03-12 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Grant (A) | +25,700 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.